Biotechnology-derived medicines are becoming a more penetrated segment and growing further with extensive research and development, which has been expanding with increasing grants and several FDA approvals for new and innovative biopharmaceuticals. A new research report “US Biotech Market Analysis", by RNCOS says that the medical biotechnology is the most important constituent of the US biotechnology sector. The need for more specialized treatment for highly prevalent diseases is primarily driving the growth of this segment, which is expected to perform exceptionally well in the future.
The need for innovation in the US is largely promoting the growth of biotechnology in the country. According to the 65 page report, the presence of a large number of unknown and chronic diseases has been creating a huge need for the innovative treatments, thereby boosting the medical biotechnology sector. The agricultural biotechnology and industrial biotechnology are also seeing novel solutions to offer more prolific and efficient products. The government support and increased funding are fuelling growth in the US biotechnology sector.
The report, which provides a comprehensive research and coherent analysis of the US biotechnology market, gives an insight into the performance of various sectors of the industry. It also includes an overview of the emerging sectors within the biotechnology which could offer new horizons in the future. The study elucidates developments in several bio-clusters in the country while throwing light on the key market players’ activities. The prudent analysis has been done to present a comprehensible picture of the sector to clients.
Some of our Related Reports are:
- Global miRNA Market Outlook
- Global HIV Therapeutics Market Analysis
- Booming Biotech Market in India
- Global Gene Therapy Market Analysis
- Global Protein Therapeutics Market Analysis
|
